bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares dropped 15.8% during mid-day trading on Wednesday . The company traded as low as $0.30 and last traded at $0.38. Approximately 8,092 shares traded hands during mid-day trading, a decline of 5% from the average daily volume of 8,522 shares. The stock had previously closed at $0.45.

bioAffinity Technologies Trading Down 15.8 %

The company has a fifty day moving average of $0.46.

Institutional Investors Weigh In On bioAffinity Technologies

An institutional investor recently bought a new position in bioAffinity Technologies stock. Armistice Capital LLC bought a new stake in shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 204,082 shares of the company's stock, valued at approximately $72,000.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.

Featured Stories

• Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
• Bed Bath & Beyond Is Circling the Drain
• Allegro Microsystems Is A Well-Positioned Semiconductor Stock
• Scotts Miracle-Gro Hits Bottom, Reversal In Play
• Altria is a Great Recession Stock, Long-Term Outlook Uncertain
• Novavax Shares Jumped in January While Others Slipped

Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.